当前位置:Public Access >页面
Chinese/English
Camrelizumab combined with radiotherapy/concurrent chemoradiotherapy for resectable oral cancer with high risk of recurrence:a prospective cohort clinical study
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。